JENNIFER WHITE-SLOUGH: Open Payments
NPI 1750646238 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 12 payments from 6 companies in 2025. Trend: 2023 $217 · 2024 $543 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $170 |
| Novo Nordisk Inc | 3 | $66 |
| PFIZER INC. | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: FARXIGA, Ozempic, AIRSUPRA, ZAVZPRET, VRAYLAR, MOUNJARO, GEMTESA.
Industry payments across KS — which companies pay providers there.
